Trial record 1 of 1 for:    NCT00607230
Previous Study | Return to List | Next Study

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David M. Nathan, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00607230
First received: January 22, 2008
Last updated: November 4, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by Massachusetts General Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):